Charlotte’s Web Holdings doesn’t need much of an introduction. While many companies were concentrating on cannabis, the Colorado-based company could see the advantages of hemp and cannabidiol (CBD) and started to develop an entire business around the specialties. Its dedication has already paid off in more ways than one and it continues to grow by leaps and bounds while many other companies remain stagnant. As the global sentiment toward CBD continues to change, Charlotte’s Web is positioned to benefit even more.
The company has a market cap of around $537 million and has a significant amount of cash – reportedly around $67 million – with which to work. Compare that amount to liabilities of just $18.3 million, and it’s easy to see the leverage it has to expand even further. That it has topped $113.8 million in revenue in the past 12 months only adds more strength to its future.
According to the company’s description, “Charlotte’s Web Hemp (CNQ: CWEB), Inc. is the market leader in the production and distribution of innovative hemp-based cannabidiol (“CBD”) wellness products. Founded by the Stanley Brothers, the Company’s premium quality products start with proprietary hemp genetics that are responsibly manufactured into whole plant hemp extracts naturally containing a full spectrum of phytocannabinoids, including CBD, terpenes, flavonoids and other beneficial hemp compounds. Industrial hemp products are non-intoxicating. Charlotte’s Web current product categories include tinctures (liquid products), capsules, topical, as well as pet products. Charlotte’s Web hemp-based whole plant extracts are sold through select distributors, brick and mortar retailers, and online through the Company’s website.”
That sums it up perfectly. Concentrating on hemp, and not marijuana, Charlotte’s Web has been able to advance further than any other US-based company in the cannabis industry. It has an unsurpassed retail presence and is not going to lose its position anytime soon.